Ocular Immunology and Inflammation: Vol 31, No 6

Por um escritor misterioso
Last updated 23 setembro 2024
Ocular Immunology and Inflammation: Vol 31, No 6
Ocular Immunology and Inflammation: Vol 31, No 6
A Mucin-Deficient Ocular Surface Mimetic Platform for Interrogating Drug Effects on Biolubrication, Antiadhesion Properties, and Barrier Functionality
Ocular Immunology and Inflammation: Vol 31, No 6
Triamcinolone acetonide, Anti-Inflammatory Agent
Ocular Immunology and Inflammation: Vol 31, No 6
Chronic White Matter Inflammation and Serum Neurofilament Levels in Multiple Sclerosis
Ocular Immunology and Inflammation: Vol 31, No 6
Bromelain supplementation and inflammatory markers: A systematic review of clinical trials - Clinical Nutrition ESPEN
Ocular Immunology and Inflammation: Vol 31, No 6
Ocular Immunology and Inflammation: Vol 31, No 6
Ocular Immunology and Inflammation: Vol 31, No 6
Frontiers Uveitis: Molecular Pathogenesis and Emerging Therapies
Ocular Immunology and Inflammation: Vol 31, No 6
Frontiers Controlling viral inflammatory lesions by rebalancing immune response patterns
Ocular Immunology and Inflammation: Vol 31, No 6
Frontiers Challenges and concepts in the diagnosis and management of ocular graft-versus-host disease
Ocular Immunology and Inflammation: Vol 31, No 6
Full article: Dry Eye as a Mucosal Autoimmune Disease
Ocular Immunology and Inflammation: Vol 31, No 6
Autoimmunity at the ocular surface: pathogenesis and regulation
Ocular Immunology and Inflammation: Vol 31, No 6
Association of pro-inflammatory systemic immune analytes to ocular
Ocular Immunology and Inflammation: Vol 31, No 6
Repeated Administration of 2-Hydroxypropyl-β-Cyclodextrin (HPβCD) Attenuates the Chronic Inflammatory Response to Experimental Stroke
Ocular Immunology and Inflammation: Vol 31, No 6
Volume 15 Issue 6, June 2022
Ocular Immunology and Inflammation: Vol 31, No 6
Table of Contents — July 19, 2022, 119 (29)
Ocular Immunology and Inflammation: Vol 31, No 6
Frontiers Roles of biomaterials in modulating the innate immune response in ocular therapy

© 2014-2024 lexenimomnia.com. All rights reserved.